A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

413

Participants

Timeline

Start Date

April 1, 2003

Primary Completion Date

November 1, 2003

Study Completion Date

November 1, 2003

Conditions

Osteoarthritis

Interventions

DRUG

MK0966, rofecoxib

DRUG

Comparator: celecoxib, placebo

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092365 - A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED) | Biotech Hunter | Biotech Hunter